US Stocks
/
Caribou Biosciences, Inc. Share Price

Caribou Biosciences, Inc. Share Price

NASDAQ: CRBU | Micro Cap
$0.46
-$0.02 (-4.4%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Caribou Biosciences, Inc. Stock Performance

Open
$0.47
Prev. Close
$0.48
Circuit Range
N/A
Day Range
$0.44 - $0.51
Year Range
$0.44 - $3.54
Volume
1,05,246
Average Traded
$0.47

Caribou Biosciences, Inc. Share Price Today

As of 10 October 2026, Caribou Biosciences, Inc.'s share price is $0.46. The stock opened at $0.47, compared to its previous close of $0.48. During today's trading session, Caribou Biosciences, Inc.'s share price traded between $0.44 and $0.51, with an average price of $0.48. Over the past 52 weeks, the stock has recorded a high of $3.54 and a low of $0.44. In terms of performance, Caribou Biosciences, Inc.'s share price has declined by 75.70% over the last six months and is down 81.05% on a year-on-year basis.

Caribou Biosciences, Inc. Share Price Chart

$0.44$0.51
L
Show Current Price
H

Caribou Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$43.00M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.97
Revenue (TTM)
$11.16B
Return On Equity (TTM)
-105.56%
Profit Margin
-1328.67%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
11.87%

Caribou Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$2.20$3.94$2.40$1.50
Net Profit-$27.55-$26.64-$25.09-$24.28
Net Profit Margin-1252.27%-676.14%-1045.42%-1618.67%
Income ChangeN/A3.30%5.82%3.23%

Caribou Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$13.85$34.48$9.99$11.16
Net Profit-$99.42-$102.07-$148.88-$148.28
Net Profit Margin-717.83%-296.03%-1490.29%-1328.67%
Income ChangeN/A-2.67%-45.86%0.40%

About Caribou Biosciences, Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Caribou Biosciences, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.28
$0.46
-63.54%
Sep 2026
$1.53
$1.27
-23.03%
Aug 2026
$1.47
$1.65
+13.79%
Jul 2026
$1.77
$1.45
-17.14%
Jun 2026
$2.35
$1.75
-25.53%
May 2026
$1.86
$2.35
+24.01%
Apr 2026
$1.97
$1.90
-0.26%
Mar 2026
$1.79
$1.90
+0.26%
Feb 2026
$1.40
$1.90
+35.36%
Jan 2026
$1.58
$1.40
-11.67%
Dec 2025
$1.84
$1.58
-18.30%
Nov 2025
$3.40
$1.94
-20.16%

CRBU Share Price FAQs

What is Caribou Biosciences, Inc. share price today?

chevron-up
Caribou Biosciences, Inc. share price today is $0.46 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Caribou Biosciences, Inc. stock?

chevron-up
The 52 week high of Caribou Biosciences, Inc. stock is $3.54, while the 52 week low is $0.44 as of 10 Oct '26.

What is CRBU's market capitalisation today?

chevron-up
CRBU market capitalisation is $43.00M as of October 10, 2026, at 4:42 am IST.

What is CRBU's net income for the last quarter?

chevron-up
CRBU's net income for the last quarter is -24.28B USD.

What is the 5 year returns of CRBU?

chevron-up
The 5 year returns of CRBU is -97.92% as on 10 Oct '26.

What is the high & low stock price of CRBU today?

chevron-up
CRBU stock price hit a high of $0.51 and low of $0.44 as of 10 Oct '26.

Can I buy CRBU shares in India?

chevron-up
Yes. You can buy CRBU in India by opening an international trading account.